More coming soon! Watch this space…

Antimicrobial effects of Ozone, NOx, RONS

Our ModuNOx™ OEM solutions and NOxLab™ R&D products allowed a rapid response to the COVID-19 pandemic with OXONOX (external link) – delivering automatic, continuous disinfection of escalator handrails and lifts – in busy public spaces such as railway stations, airports and retail hubs.

External links:

Our NOxLab™ R&D products have also been used in applied microbiology studies at the universities of Surrey, Hull and Cardiff – in the contexts of wound care, food processing and hard surface disinfection – funded by the National Biofilms Innovation Centre (NBIC) and Innovate UK.

In these studies our devices showed >99.99% effectiveness against many bacterial (and one fungal) species – including antimicrobial-resistant strains – plus the ability to delay biofilm formation.

External links:

Bioactive effects of Ozone, NOx, RONS

Our NOxLab™ R&D products have been used in wound healing & dermatology research by a medtech multinational, University of Hull (British Skin Foundation, National Biofilms Innovation Centre and Innovate UK) and Queen Mary University of London (MedCity).

In these studies, our partners demonstrated stimulation of bioprocesses linked to tissue growth (cell proliferation, migration).

We are also providing ModuNOx™ OEM solutions to a producer of plant-based cosmetics, to optimise plant growth with NOx gases.

External links:

Chemical effects of Ozone, NOx, RONS

We’ve worked closely with the National Physical Laboratory (NPL) and Surrey Space Centre over many years to comprehensively characterise the chemical outputs of our devices – funded by Innovate UK, the Space Research & Innovation Network for Technology (SPRINT) and EPSRC Impact Acceleration Account.

We are also providing ModuNOx™ OEM solutions to a supplier in the energy / heavy industry sector, replacing compressed NOx gas cylinders which are expensive and impractical at scale.

External links: